EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Respiratory complex I‐mediated NAD + regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21 Cip1 expression by SIRT3 and SIRT7

Masato Higurashi, Kazunori Mori iD, Hidetsugu Nakagawa, Momoko Uchida, Fumihiro Ishikawa, Motoko Shibanuma iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Masato Higurashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Cell Biology, Department of Pharmaceutical Sciences, Showa University Graduate School of Pharmacy, Tokyo, Japan. Hauptthemen laut MEDLINE: Sirtuin 3, Sirtuins, Electron Transport Complex I, NAD. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of the electron transport chain (ETC) in cell proliferation control beyond its crucial function in supporting ATP generation has recently emerged. In this study, we found that, among the four ETC complexes, the complex I (CI)‐mediated NAD + regeneration is important for cancer cell proliferation. In cancer cells, a decrease in CI activity by RNA interference (RNAi) against NADH:ubiquinone oxidoreductase core subunit V1 ( NDUFV1 ) arrested the cell cycle at the G 1 /S phase, accompanying upregulation of p21 Cip1 cyclin‐dependent kinase inhibitor expression. Mechanistically, a decrease in the NAD + /NADH ratio downregulated SIRT3 and SIRT7 function, which suppressed p21 Cip1 expression at the translational and transcriptional levels, respectively, resulting in the upregulation of the antiproliferative molecule. Importantly, high expression levels of the core subunits of CI correlated with poor prognosis in patients with the hormone receptor(+)/human epidermal growth factor receptor 2(−) (HR+/HER2−) subtype of breast cancer. Therefore, NDUFV1 and SIRT3/7 have emerged as promising therapeutic targets against this breast cancer subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 3SirtuinsElectron Transport Complex INADCyclin-Dependent Kinase Inhibitor p21Breast NeoplasmsGene Expression Regulation, NeoplasticTranscription, GeneticProtein BiosynthesisHumansCell ProliferationCell Line, TumorFemaleMCF-7 Cells

Stichwörter der Autor:innen

NAD+SIRTbreast cancerp21Cip1respiratory complex I

Substanzen

Sirtuin 3SirtuinsElectron Transport Complex ISIRT7 protein, humanNADCyclin-Dependent Kinase Inhibitor p21SIRT3 protein, humanCDKN1A protein, human

Autor:innen und Institutionen

  • Division of Cancer Cell Biology, Department of Pharmaceutical Sciences, Showa University Graduate School of Pharmacy, Tokyo, Japan.
  • Center for Biotechnology, Showa University, Tokyo, Japan.

ORCID-Profile: Kazunori Mori, Motoko Shibanuma

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Higurashi, M., Mori, K., Nakagawa, H., Uchida, M., Ishikawa, F., & Shibanuma, M. (2025). Respiratory complex I‐mediated NAD + regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21 Cip1 expression by SIRT3 and SIRT7. Molecular Oncology. https://doi.org/10.1002/1878-0261.13808

Vancouver

Higurashi M, Mori K, Nakagawa H, Uchida M, Ishikawa F, Shibanuma M. Respiratory complex I‐mediated NAD + regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21 Cip1 expression by SIRT3 and SIRT7. Molecular Oncology. 2025. doi:10.1002/1878-0261.13808

BibTeX
@article{Higurashi2025,
  author = {Higurashi, Masato and Mori, Kazunori and Nakagawa, Hidetsugu and Uchida, Momoko and Ishikawa, Fumihiro and Shibanuma, Motoko},
  title = {Respiratory complex I‐mediated NAD + regeneration regulates cancer cell proliferation through the transcriptional and translational control of p21 Cip1 expression by SIRT3 and SIRT7},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13808}
}
Kostenlos starten →